Coeliac Disease and Fatty Liver: Key Facts

Coeliac disease and fatty liver disease are two conditions that can occur together more often than chance alone would suggest. In people with coeliac disease, intestinal inflammation, increased gut permeability, and malabsorption of key nutrients are all thought to contribute to fat accumulation in the liver. Understanding the link between coeliac disease and fatty liver is important for timely diagnosis and effective management. This article explains why the two conditions are connected, what symptoms to watch for, how a gluten-free diet may help, and what long-term care looks like on the NHS.

Can coeliac disease cause fatty liver disease?

Coeliac disease can cause fatty liver disease by increasing gut permeability and promoting inflammation that drives fat accumulation in liver cells. NICE NG20 recommends liver function tests at diagnosis, as liver involvement is a recognised extra-intestinal manifestation.

Coeliac disease can contribute to the development of fatty liver disease, a condition in which excess fat accumulates within liver cells. The relationship between the two conditions is well recognised in gastroenterology, and studies have found that a proportion of people with coeliac disease have elevated liver enzymes or evidence of hepatic steatosis (fatty change in the liver) at the time of diagnosis.^[3][6] The mechanism is not fully understood, but intestinal inflammation, increased gut permeability, and malabsorption of key nutrients are all thought to play a role.

When the small intestine is damaged by the immune response to gluten, the gut lining becomes more permeable than normal. This allows bacterial products and inflammatory signals to pass more readily into the portal circulation, which drains directly into the liver. The liver then responds with low-grade inflammation, which over time may promote fat deposition within hepatocytes (liver cells).

It is worth noting that not all abnormal liver function tests in coeliac disease are caused by fatty liver. Other causes, including autoimmune hepatitis, which can occur alongside coeliac disease, as well as viral hepatitis and drug-related liver injury, should be considered and excluded where appropriate.^[4][5]

Not everyone with coeliac disease will develop fatty liver disease, and the severity varies considerably between individuals. Other factors, including body weight, alcohol intake, and metabolic health, also influence liver fat accumulation. NICE guidance on coeliac disease (NG20) recommends checking liver function tests at diagnosis, recognising that liver involvement is a recognised extra-intestinal manifestation of the condition.^[1]

The term NAFLD (non-alcoholic fatty liver disease) is used throughout this article in line with NICE NG49. You may also encounter the newer term MASLD (metabolic dysfunction-associated steatotic liver disease), which reflects updated international nomenclature and broadly covers the same condition.^[18][19]

Why do these two conditions so often occur together?

Coeliac disease and NAFLD share overlapping mechanisms including intestinal inflammation, nutrient deficiencies, and gut dysbiosis, all of which can promote hepatic fat deposition. A gluten-free diet higher in refined carbohydrates may also introduce new metabolic risk factors after diagnosis.

Coeliac disease and non-alcoholic fatty liver disease (NAFLD) share several overlapping biological pathways, which helps explain why they are found together more frequently than would be expected by chance. Published reviews and meta-analyses have reported a higher prevalence of abnormal liver function tests and hepatic steatosis in people with coeliac disease compared with the general population, though estimates vary between studies.^[10][11] Chronic intestinal inflammation, nutrient deficiencies, and alterations in the gut microbiome are among the most important shared mechanisms.

Malabsorption is a central feature of untreated coeliac disease. Deficiencies in choline, folate, and fat-soluble vitamins (A, D, E, and K) may impair the liver's ability to process and export fats efficiently, potentially promoting their accumulation. Low levels of choline in particular have been associated with hepatic steatosis, as choline is essential for the synthesis of phosphatidylcholine, a molecule needed to package and transport fat out of the liver.^[6][7]

The gut microbiome also appears to be disrupted in both conditions. Dysbiosis, an imbalance in the community of bacteria living in the gut, is documented in coeliac disease and has independently been linked to NAFLD.^[6][9] Bacterial metabolites produced in a dysbiotic gut can reach the liver via the portal vein and trigger inflammatory and metabolic changes that may favour fat deposition.

There is emerging evidence of shared genetic susceptibility between autoimmune conditions and metabolic liver disease, though this area of research is still developing and findings should be interpreted cautiously.

It is also worth noting that after diagnosis, some people with coeliac disease gain weight as intestinal absorption improves. This, combined with a gluten-free diet that may be higher in refined carbohydrates, can introduce or worsen metabolic risk factors for NAFLD even in people who are adherent to their diet. Clinicians should be aware that persistently abnormal liver function tests in a person with coeliac disease warrant further investigation, even when the person is otherwise well.

What symptoms should prompt you to speak to your GP?

Speak to your GP if you have coeliac disease and develop persistent fatigue, right-sided upper abdominal discomfort, unexplained weight changes, or jaundice. Call 999 immediately for sudden jaundice, vomiting blood, black stools, or new confusion.

You should speak to your GP if you have known coeliac disease and develop new or worsening symptoms that could suggest liver involvement, including persistent fatigue, right-sided upper abdominal discomfort, unexplained weight changes, or yellowing of the skin or whites of the eyes (jaundice).

Some symptoms require more urgent attention. Call 999 or go to your nearest A&E department if you experience any of the following, as they may indicate serious liver disease:

• Sudden or rapidly worsening jaundice

• Vomiting blood or passing black, tarry stools

• New confusion, drowsiness, or difficulty thinking clearly (which may suggest hepatic encephalopathy)

• Severe abdominal pain with fever

If you are unsure whether your symptoms are urgent, contact NHS 111 for advice.

Many people with fatty liver disease have no symptoms at all in the early stages, which is why routine monitoring matters. If you have coeliac disease and have not had your liver function checked recently, it is reasonable to raise this with your GP, particularly if you have other risk factors such as being overweight, having type 2 diabetes, or consuming alcohol regularly.

Symptoms that may suggest your coeliac disease is not well controlled, and which could indirectly affect liver health, include:

• Ongoing diarrhoea, bloating or abdominal pain despite following a gluten-free diet

• Unexplained anaemia or fatigue

• Mouth ulcers or a skin rash consistent with dermatitis herpetiformis

• Bone pain or frequent fractures, which may indicate ongoing malabsorption

If you are unsure whether your symptoms are related to coeliac disease, liver disease, or another cause entirely, your GP can arrange blood tests including liver function tests, coeliac antibody levels, and a full blood count to help guide further investigation. Where liver involvement is suspected, your GP may also check thyroid function, iron studies, vitamin D, and B12 and folate levels. NICE NG49 recommends that GPs use a first-line fibrosis risk score, such as the FIB-4 index or the NAFLD Fibrosis Score (NFS), to help identify people who need further assessment.^[2] Early identification of liver abnormalities gives the best opportunity for intervention before significant damage occurs.

Does a gluten-free diet help improve liver health?

A strict gluten-free diet can improve liver health by healing the gut lining and reducing inflammatory signals reaching the liver, with some studies reporting normalisation of liver enzymes within months. However, it is not a guaranteed cure, particularly if other metabolic risk factors are present.

A strict gluten-free diet does appear to improve liver health in many people with coeliac disease, and this is one of the most encouraging aspects of managing both conditions together. Studies have reported normalisation of elevated liver enzymes in a proportion of people after starting a gluten-free diet, often within several months, though the timeframe varies between individuals and is not guaranteed.^[6][7] The evidence base is largely observational, so findings should be interpreted with appropriate caution.

The proposed mechanism is that healing of the intestinal lining reduces gut permeability, which in turn decreases the flow of inflammatory signals and bacterial products into the portal circulation. As intestinal absorption improves, nutritional deficiencies that may contribute to hepatic steatosis, such as low choline and fat-soluble vitamins, are also corrected over time.

However, a gluten-free diet is not a guaranteed cure for fatty liver disease, particularly if other contributing factors are present. A gluten-free diet can sometimes be higher in refined carbohydrates and saturated fats than a standard diet, especially when relying heavily on processed gluten-free products. This dietary pattern can itself promote fat accumulation in the liver if not managed carefully. Guidance from Coeliac UK and the British Dietetic Association (BDA) emphasises the importance of building a gluten-free diet around naturally gluten-free whole foods, such as vegetables, legumes, rice, and potatoes, rather than relying on processed substitutes. Dietetic support is therefore valuable, both to ensure the diet is nutritionally complete and to avoid inadvertent metabolic risk.

For people with coeliac disease and established NAFLD, lifestyle measures recommended by NICE NG49 for NAFLD more broadly, including achieving and maintaining a healthy weight, limiting alcohol, and taking regular physical activity, remain relevant alongside dietary gluten avoidance. The two approaches are complementary rather than alternatives.

Treatment and long-term management on the NHS

NHS management combines a lifelong gluten-free diet with annual review of liver function, fibrosis risk scoring using FIB-4 or NFS, and referral to hepatology if liver tests remain abnormal. Modifiable risk factors including weight, alcohol, and coexisting conditions such as type 2 diabetes are addressed alongside dietary measures.

Long-term management of coeliac disease and associated fatty liver disease on the NHS centres on a strict, lifelong gluten-free diet, supported by regular monitoring and a multidisciplinary approach. NICE guidance NG20 recommends that people with coeliac disease receive annual review, which should include assessment of dietary adherence, nutritional status, and relevant blood tests including liver function.^[1]

For fatty liver disease, NICE guidance NG49 recommends a staged approach to investigation and monitoring based on the degree of liver fibrosis. In primary care, the first step is typically a non-invasive fibrosis risk score, such as the FIB-4 index or the NAFLD Fibrosis Score (NFS), calculated from routine blood tests. Those identified as being at higher risk of significant fibrosis may then be referred for second-line assessment using tools such as the enhanced liver fibrosis (ELF) test or transient elastography (for example, FibroScan). People with coeliac disease who have persistently abnormal liver function tests despite adherence to a gluten-free diet warrant hepatology referral for further assessment.

There is currently no licensed pharmacological treatment specifically for NAFLD in the UK, so management focuses on addressing modifiable risk factors.^[15][16] These include:

• Achieving a healthy body weight through dietary change and physical activity

• Reducing or eliminating alcohol consumption. The UK Chief Medical Officers recommend that both men and women keep alcohol consumption to no more than 14 units per week, spread over three or more days, with several alcohol-free days each week.^[17] People with established liver disease are generally advised to avoid alcohol altogether

• Optimising control of any coexisting conditions such as type 2 diabetes or raised cholesterol

• Ensuring nutritional deficiencies identified at coeliac diagnosis are corrected, with supplementation where necessary

Referral to a registered dietitian with experience in coeliac disease is recommended for all newly diagnosed patients and is particularly important for those with evidence of liver involvement. People seeking further information about accessing specialist dietary or medical support can speak to their GP, who can refer through the appropriate NHS pathway. Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online consultations with prescriber review and pharmacist support, which may be relevant for those managing related conditions alongside coeliac disease.

Scientific References

1. Coeliac disease: recognition, assessment and management (NG20).
2. Non-alcoholic fatty liver disease (NAFLD): assessment and management (NG49).
3. Long-term risk of chronic liver disease in patients with coeliac disease.
4. Coeliac disease in autoimmune liver disease: a cross-sectional study.
5. High prevalence of celiac disease in autoimmune hepatitis.
6. Celiac Disease and Liver Disorders: From Putative Pathogenesis to Clinical Implications.
7. Gluten's silent strike: Unmasking its impact on liver health.
8. The connection between fatty acids and inflammation in celiac disease; a deep exploring.
9. The role of gut microbiota in intestinal and liver diseases.
10. Prevalence and Risk Factors of Celiac Disease in Patients With Non-Alcoholic Fatty Liver Disease: A Meta-Analysis.
11. Patients with Celiac Disease Have High Prevalence of Fatty Liver and Metabolic Syndrome.
12. Elevated liver enzymes of newly diagnosed pediatric celiac patients – a prospective-observational study.
13. Hepatic Steatosis and Diet in Adult Celiac Disease: A Cross-Sectional Study.
14. Influence of a structured, 1-year-long dietary intervention regarding body composition and cardiovascular risk (ARCTIC) in coeliac disease.
15. Non-alcoholic fatty liver disease (NAFLD).
16. Resmetirom (Rezdiffra) authorised to treat metabolic dysfunction-associated steatohepatitis (MASH) in adults.
17. UK Chief Medical Officers' Low Risk Drinking Guidelines (Chapter 12: Alcohol).
18. Understanding the evolving nomenclature of steatotic liver disease.
19. Natural history and outcomes of MASLD and MetALD following non-alcoholic fatty liver disease reclassification in a Canadian cohort.

Frequently Asked Questions